Omena Company Profile

Background

Company Overview

Omena is a Paris-based FemTech startup founded in 2021 by Mathilde Nême, Jane Douat, and Hahyeon Park, who initiated the venture while studying at HEC Paris business school. The company focuses on providing comprehensive support and services to women experiencing perimenopause and menopause through its digital health application. Recognizing a gap in the French market where topics like endometriosis and pregnancy received more attention from tech startups than menopause, Omena aims to address this underserved area.

Mission and Vision

Omena's mission is to empower menopausal women by offering personalized information about menopause symptoms, treatment options, and associated health risks, thereby enhancing their quality of life during this life stage. The company's vision is to become a leading provider of digital health solutions for women in perimenopause and menopause, fostering a supportive community and promoting informed health decisions.

Industry Significance

Operating within the FemTech sector, Omena addresses a significant market need, as only 6% of FemTech companies in France focus on menopause, despite 500,000 women entering menopause annually in the country. Globally, startups tackling issues related to menopause have raised only 1.3% of global FemTech funds between 2012 and 2021, highlighting the potential for growth and impact in this niche.

Key Strategic Focus

Core Objectives

Empowerment through Information: Provide accurate and personalized information about menopause symptoms, treatment options, and associated health risks.

Community Building: Foster a supportive community where women can share experiences, advice, and support.

Expansion and Accessibility: Expand the app's reach to other countries in continental Europe and explore additional revenue streams.

Areas of Specialization

Digital Health Solutions: Develop and maintain a user-friendly mobile application tailored for women experiencing perimenopause and menopause.

Personalized Wellness Programs: Offer customized wellness programs addressing specific symptoms such as hot flashes, insomnia, anxiety, and joint pain.

Key Technologies Utilized

Mobile Application Development: Utilize advanced mobile app development technologies to create an intuitive and accessible user experience.

Data Analytics: Employ data analytics to personalize wellness programs and track user progress effectively.

Primary Markets Targeted

Geographical Markets: Initially focusing on France, with plans to expand to other countries in continental Europe.

Demographic Markets: Women experiencing perimenopause and menopause, particularly those seeking digital health solutions and community support.

Financials and Funding

Funding History

Pre-Seed Round (2021): Raised €400,000 to develop the initial version of the app and establish the brand.

Seed Round (January 2024): Secured €800,000, including €600,000 in equity, to enhance marketing efforts, expand the user base, and explore additional revenue streams.

Notable Investors

Alexandre Lebrun: Founder of AI healthtech Nabla.

Marie Outtier: Angel investor.

Simon Dawlat: CEO of CRM startup Batch.

Fair Equity: French family office.

Mozza Angels: Investor club.

Utilization of Capital

Marketing and User Acquisition: Intensify marketing efforts to elevate the conversation around menopause in France and attract a broader user base.

Product Development: Enhance the app's features and expand its offerings to meet user needs effectively.

Business Development: Forge B2B partnerships, explore collaborations with health insurance companies, and develop an e-shop for GEMVI-approved products.

Pipeline Development

Key Pipeline Candidates

Mobile Application: The primary product offering personalized information and support services to menopausal women.

Stages of Development

Launch and Early Growth: Launched in March 2022, the app has attracted 55,000 users by January 2024, with a significant portion opting for the paid membership.

Target Conditions

Menopause Symptoms: Addressing a range of symptoms including hot flashes, sleep disturbances, anxiety, and depression.

Anticipated Milestones

User Base Expansion: Aim to increase the user base significantly through enhanced marketing and partnerships.

Revenue Growth: Increase revenue through premium subscriptions, B2B partnerships, and additional revenue streams.

Technological Platform and Innovation

Proprietary Technologies

Personalized Wellness Programs: Customized programs based on user input to address specific menopause symptoms.

Significant Scientific Methods

Partnership with GEMVI: Collaboration with GEMVI, a French scientific organization specializing in menopause, ensures the medical accuracy of the app's content.

Leadership Team

Key Executives

Mathilde Nême: Co-founder and CEO.

Jane Douat: Co-founder.

Hahyeon Park: Co-founder.

Professional Backgrounds

Mathilde Nême: Co-founded Omena while studying at HEC Paris business school, bringing a strong background in business and entrepreneurship.

Jane Douat and Hahyeon Park: Both co-founders initiated the venture during their studies at HEC Paris, contributing diverse skills and perspectives to the company.

Key Contributions

Mathilde Nême: As CEO, she leads the company's strategic direction, fundraising efforts, and partnerships.

Jane Douat and Hahyeon Park: Contribute to product development, user experience design, and operational management.

Competitor and Market Overview

Market Insights and Dynamics

Market Size and Growth Potential: The FemTech sector is experiencing rapid growth, with increasing attention to women's health issues, including menopause.

Industry Trends: Growing demand for digital health solutions, personalized wellness programs, and supportive communities for women in perimenopause and menopause.

Competitive Landscape

Key Competitors: Other FemTech companies focusing on women's health, particularly those addressing menopause symptoms and support.

Differentiation: Omena's focus on personalized wellness programs and community support distinguishes it from competitors in the market.

Strategic Collaborations and Partnerships

Significant Collaborations

GEMVI: Partnership with GEMVI, a French scientific organization specializing in menopause, ensures the medical accuracy of the app's content.

B2B Partnerships

Health Insurance Companies: Exploring collaborations to include Omena's services in health insurance offerings.

Corporate Wellness Programs: Targeting companies with the "Menopause Friendly Accreditation" label to implement supportive measures for menopausal employees.

Operational Insights

Strategic Considerations

Market Position: Omena positions itself as a leading provider of digital health solutions for women in perimenopause and menopause, focusing on personalized support and community engagement.